These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28356902)

  • 21. The Joint European Compound Library: boosting precompetitive research.
    Besnard J; Jones PS; Hopkins AL; Pannifer AD
    Drug Discov Today; 2015 Feb; 20(2):181-6. PubMed ID: 25205347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anthelmintic drug discovery: target identification, screening methods and the role of open science.
    Partridge FA; Forman R; Bataille CJR; Wynne GM; Nick M; Russell AJ; Else KJ; Sattelle DB
    Beilstein J Org Chem; 2020; 16():1203-1224. PubMed ID: 32550933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can open-source drug R&D repower pharmaceutical innovation?
    Munos B
    Clin Pharmacol Ther; 2010 May; 87(5):534-6. PubMed ID: 20407458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Balancing Benefits and Risks of Immortal Data: Participants' Views of Open Consent in the Personal Genome Project.
    Zarate OA; Brody JG; Brown P; Ramirez-Andreotta MD; Perovich L; Matz J
    Hastings Cent Rep; 2016; 46(1):36-45. PubMed ID: 26678513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Open innovation in early drug discovery: roadmaps and roadblocks.
    Reichman M; Simpson PB
    Drug Discov Today; 2016 May; 21(5):779-88. PubMed ID: 26743597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expectation for the drug development activity in academia].
    Inagaki O
    Yakugaku Zasshi; 2013; 133(2):213-9. PubMed ID: 23370516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies for bringing drug delivery tools into discovery.
    Kwong E; Higgins J; Templeton AC
    Int J Pharm; 2011 Jun; 412(1-2):1-7. PubMed ID: 21421040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crowdsourcing in pharmaceutical R&D: a revolutionary concept or nothing new?
    Song CH
    Pharm Pat Anal; 2016 Sep; 5(6):355-360. PubMed ID: 27804785
    [No Abstract]   [Full Text] [Related]  

  • 29. Natural products as probes in pharmaceutical research.
    Schmitt EK; Hoepfner D; Krastel P
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):249-60. PubMed ID: 26438431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Open-access public-private partnerships to enable drug discovery--new approaches.
    Müller S; Weigelt J
    IDrugs; 2010 Mar; 13(3):175-80. PubMed ID: 20191434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developing good scientific publishing practices: one pharmaceutical company's perspective.
    Dowsett SA; Van Campen LE; Bednar LA
    Curr Med Res Opin; 2010 Jun; 26(6):1249-54. PubMed ID: 20350148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collective intelligence for translational medicine: Crowdsourcing insights and innovation from an interdisciplinary biomedical research community.
    Budge EJ; Tsoti SM; Howgate DJ; Sivakumar S; Jalali M
    Ann Med; 2015; 47(7):570-5. PubMed ID: 26469375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. International guidelines for groin hernia management.
    HerniaSurge Group
    Hernia; 2018 Feb; 22(1):1-165. PubMed ID: 29330835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond.
    Van Voorhis WC; Adams JH; Adelfio R; Ahyong V; Akabas MH; Alano P; Alday A; Alemán Resto Y; Alsibaee A; Alzualde A; Andrews KT; Avery SV; Avery VM; Ayong L; Baker M; Baker S; Ben Mamoun C; Bhatia S; Bickle Q; Bounaadja L; Bowling T; Bosch J; Boucher LE; Boyom FF; Brea J; Brennan M; Burton A; Caffrey CR; Camarda G; Carrasquilla M; Carter D; Belen Cassera M; Chih-Chien Cheng K; Chindaudomsate W; Chubb A; Colon BL; Colón-López DD; Corbett Y; Crowther GJ; Cowan N; D'Alessandro S; Le Dang N; Delves M; DeRisi JL; Du AY; Duffy S; Abd El-Salam El-Sayed S; Ferdig MT; Fernández Robledo JA; Fidock DA; Florent I; Fokou PV; Galstian A; Gamo FJ; Gokool S; Gold B; Golub T; Goldgof GM; Guha R; Guiguemde WA; Gural N; Guy RK; Hansen MA; Hanson KK; Hemphill A; Hooft van Huijsduijnen R; Horii T; Horrocks P; Hughes TB; Huston C; Igarashi I; Ingram-Sieber K; Itoe MA; Jadhav A; Naranuntarat Jensen A; Jensen LT; Jiang RH; Kaiser A; Keiser J; Ketas T; Kicka S; Kim S; Kirk K; Kumar VP; Kyle DE; Lafuente MJ; Landfear S; Lee N; Lee S; Lehane AM; Li F; Little D; Liu L; Llinás M; Loza MI; Lubar A; Lucantoni L; Lucet I; Maes L; Mancama D; Mansour NR; March S; McGowan S; Medina Vera I; Meister S; Mercer L; Mestres J; Mfopa AN; Misra RN; Moon S; Moore JP; Morais Rodrigues da Costa F; Müller J; Muriana A; Nakazawa Hewitt S; Nare B; Nathan C; Narraidoo N; Nawaratna S; Ojo KK; Ortiz D; Panic G; Papadatos G; Parapini S; Patra K; Pham N; Prats S; Plouffe DM; Poulsen SA; Pradhan A; Quevedo C; Quinn RJ; Rice CA; Abdo Rizk M; Ruecker A; St Onge R; Salgado Ferreira R; Samra J; Robinett NG; Schlecht U; Schmitt M; Silva Villela F; Silvestrini F; Sinden R; Smith DA; Soldati T; Spitzmüller A; Stamm SM; Sullivan DJ; Sullivan W; Suresh S; Suzuki BM; Suzuki Y; Swamidass SJ; Taramelli D; Tchokouaha LR; Theron A; Thomas D; Tonissen KF; Townson S; Tripathi AK; Trofimov V; Udenze KO; Ullah I; Vallieres C; Vigil E; Vinetz JM; Voong Vinh P; Vu H; Watanabe NA; Weatherby K; White PM; Wilks AF; Winzeler EA; Wojcik E; Wree M; Wu W; Yokoyama N; Zollo PH; Abla N; Blasco B; Burrows J; Laleu B; Leroy D; Spangenberg T; Wells T; Willis PA
    PLoS Pathog; 2016 Jul; 12(7):e1005763. PubMed ID: 27467575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery and development of new antibacterial drugs: learning from experience?
    Jackson N; Czaplewski L; Piddock LJV
    J Antimicrob Chemother; 2018 Jun; 73(6):1452-1459. PubMed ID: 29438542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The successes and challenges of open-source biopharmaceutical innovation.
    Allarakhia M
    Expert Opin Drug Discov; 2014 May; 9(5):459-65. PubMed ID: 24702304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Open Access Could Transform Drug Discovery: A Case Study of JQ1.
    Arshad Z; Smith J; Roberts M; Lee WH; Davies B; Bure K; Hollander GA; Dopson S; Bountra C; Brindley D
    Expert Opin Drug Discov; 2016; 11(3):321-32. PubMed ID: 26791045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.